These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32123046)

  • 1. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
    Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
    Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
    Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.
    Saraste M; Bezukladova S; Matilainen M; Sucksdorff M; Kuhle J; Leppert D; Airas L
    Mult Scler Relat Disord; 2021 May; 50():102810. PubMed ID: 33556656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
    Shi Z; Pan Y; Yan Z; Ding S; Hu H; Wei Y; Luo D; Xu Y; Zhu Q; Li Y
    Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Feng J; Luo T; Li Y
    Eur Radiol; 2024 Aug; 34(8):5263-5275. PubMed ID: 38175221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging.
    Caranova M; Soares JF; Batista S; Castelo-Branco M; Duarte JV
    Magn Reson Imaging; 2023 Dec; 104():61-71. PubMed ID: 37775062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging.
    Yu FF; Chiang FL; Stephens N; Huang SY; Bilgic B; Tantiwongkosi B; Romero R
    Neuroradiology; 2019 Jan; 61(1):71-79. PubMed ID: 30539215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis.
    Hannoun S; Kocevar G; Codjia P; Barile B; Cotton F; Durand-Dubief F; Sappey-Marinier D
    J Neuroimaging; 2022 Mar; 32(2):328-336. PubMed ID: 34752685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
    Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
    Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
    Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
    Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
    BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS.
    Alshehri A; Koussis N; Al-Iedani O; Arm J; Khormi I; Lea S; Lea R; Ramadan S; Lechner-Scott J
    Eur J Radiol; 2024 Jan; 170():111207. PubMed ID: 37988961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
    Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
    Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
    J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
    Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
    Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.